predictXbio
Founded 2023 · 1 employees on LinkedIn · 1 known investors
Find your way into predictXbio
23 people in our graph share verified history with the predictXbio team — schools, employers, funds. One of them is your warm intro.
Ryan Longunlockedknows Cory Kromer-Edwards · together at University of Iowa (overlapped)
×11knows the team · via University of Iowa
PredictXBio uses AI, machine learning, and bioinformatics pipelines to predict how pathogens respond to drugs and to model antimicrobial potency in silico, aiming to accelerate discovery of antimicrobials against antimicrobial resistance. Its tools serve drug developers by predicting future resistance mutations and testing therapeutic compounds computationally.
Founders & leadership
predictXbio was founded in 2023 by Cory Kromer-Edwards.
CK
Cory Kromer-EdwardsinFounder/CEOCory Kromer-Edwards is the founder and CEO of PredictXBio, which develops machine learning and bioinformatics tools to predict pathogen drug resistance and model antimicrobial potency.
RD
Russ DondainChief Strategy Officer
Investors · 1
Frequently asked questions
- What does predictXbio do?
- PredictXBio uses AI, machine learning, and bioinformatics pipelines to predict how pathogens respond to drugs and to model antimicrobial potency in silico, aiming to accelerate discovery of antimicrobials against antimicrobial resistance. Its tools serve drug developers by predicting future resistance mutations and testing therapeutic compounds computationally.
- Who founded predictXbio?
- predictXbio was founded by Cory Kromer-Edwards in 2023.
- Who are predictXbio's investors?
- predictXbio's investors include JumpStart Equity.